Abstract: Provided is a new conotoxin peptide ?-CPTx-btl02. The conotoxin peptide ?-CPTx-btl02 has derivative polypeptide that has an amino acid sequence indicated by SEQ ID NO:1, or has derivative polypeptide that has an amino acid sequence indicated by SEQ ID NO:1 and that is formed after substitution, addition or deletion of one or more amino acids are performed and has original functions. Also provided is polynucleotide for coding the peptide, comprising a constructed body of the polynucleotide, an expression carrier and transformed cells. A peptide preparation method and uses in the treatment of diseases related to a calcium ion channel.

Abstract: Systems and/or techniques associated with a solid-state microbattery packaging system are provided. In one example, a device comprises a substrate layer and a tape substrate layer. The substrate layer is associated with a set of solid-state microbattery components. The tape substrate comprises a releasable adhesive material and a polymer sealing material. A conductive surface associated with the set of solid-state microbattery components is disposed on the releasable adhesive material of the tape substrate layer.

Abstract: Systems and/or techniques associated with a solid-state microbattery packaging system are provided. In one example, a device comprises a substrate layer and a tape substrate layer. The substrate layer is associated with a set of solid-state microbattery components. The tape substrate comprises a releasable adhesive material and a polymer sealing material. A conductive surface associated with the set of solid-state microbattery components is disposed on the releasable adhesive material of the tape substrate layer.

Abstract: Provided are a conotoxin peptide ?-CPTx-btl04 and a derivative polypeptide. The amino acid sequence of the conotoxin peptide is indicated by SEQ ID NO: 1. Also provided are a conotoxin peptide preparation method and uses of the conotoxin peptide in the treatment of diseases related to a calcium ion channel.

Abstract: Disclosed herein is novel double-stranded short interfering ribonucleic acid (siRNA) capable of suppressing the translation of Aurora-A mRNA. Also disclosed are use of the novel siRNA as disclosed herein for manufacturing a medicament suitable for treating a cancer, which is mediated through epidermal growth factor receptor (EGFR) signaling. Accordingly, a pharmaceutical composition comprising the disclosed novel siRNA molecules is provided; as well as a method of treating a subject suffering from EGFR-mediated cancer via administering to the subject the disclosed novel siRNA molecule.

Abstract: A semiconductor structure and a method for forming the same are provided. The semiconductor structure includes a gate stack structure formed over a substrate. The gate stack structure includes a gate electrode structure having a first portion and a second portion and a first conductive layer below the gate electrode structure. In addition, the first portion of the gate electrode structure is located over the second portion of the gate electrode structure, and a width of a top surface of the first portion of the gate electrode structure is greater than a width of a bottom surface of the second portion of the gate electrode structure.

Abstract: A head-mounted display device including a display system and a light modulator is provided. The display system is configured to selectively display a first content to be visually recognized as being superimposed on a scenery of a surrounding environment, or not display the first content. The light modulator, positioned between the display system and the surrounding environment, includes an array of pixels, wherein a portion of the pixels is configured to modulate light to present a display of a second content, while the rest of the pixels are configured to be substantially transparent to light.

Abstract: A gate structure includes at least one spacer defining a gate region over a semiconductor substrate, a gate dielectric layer disposed on the gate region over the semiconductor substrate, a first work function metal layer disposed over the gate dielectric layer and lining a bottom surface of an inner sidewall of the spacer, and a filling metal partially wrapped by the first work function metal layer. The filling metal includes a first portion and a second portion, wherein the first portion is between the second portion and the semiconductor substrate, and the second portion is wider than the first portion.

Abstract: Disclosed are a conotoxin polypeptide ?-CPTx-bt101, a method for preparation thereof, and an application thereof. The conotoxin polypeptide of the present invention consists of 18 amino acids, has a molecular weight of 1872.72 daltons, and has the full sequence KCCTMSVCQPPPVCTCCA (SEQ. ID NO. 1).

Abstract: A processor and a task processing method therefor, and a storage medium. The method comprises: a scalar calculation module executing parameter calculation of a current task, and storing a parameter obtained through calculation in a PBUF; when the parameter calculation of the current task is completed, executing a first instruction or second instruction for inter-core synchronization, and storing the first instruction or the second instruction in the PBUF (301); a vector calculation module reading the parameter from the PBUF, storing the read parameter in a shadow register; when the first instruction or the second instruction is read from the PBUF, storing all the modified parameters in the shadow register in a work register within a period (302); and the vector calculation module executing vector calculation of the current task according to the parameter in the work register (303).

Abstract: A stroller includes a chassis and a child support. The chassis is configured to roll along the ground in response to being pushed by a caregiver. The child support is coupled selectively to the chassis and is configured to support a child resting therein.

Abstract: A head mounted display device, an object tracking apparatus and a method for tracking object thereof are provided. The object tracking apparatus includes a lens, a light splitting device, a programmable light source and an image extractor. The lens generates and projects a detection light beam to an object. The programmable light source has a plurality of sub-light sources. The sub-light sources respectively project a plurality of light beams to a plurality of positions of the light splitting device. The programmable light source receives a driving signal, and adjusts a light-on status of each of the sub-light sources according to the driving signal. The image extractor extracts a detection image from the object. Wherein, the light splitting device receives at least one of the light beams and generates at least one reflection light beam to the lens, and the lens generates the detection light beam accordingly.

Abstract: A head mounted display (HMD) device and an image projection method are provided. The head mounted display device includes an optical waveguide device, an image device, an optical conversion layer and a processor. The optical waveguide device receives an image light beam and projects a projection image through a surface. The image device is used to provide the image light beam. The optical conversion layer is disposed overlapping the edge of the surface of the optical waveguide device. The optical conversion layer deflects a portion of the projection image to generate an adjusted projection image according to a command signal, so that the adjusted projection image is transmitted to a projection target. The processor generates the command signal according to a position of the projection target.

Abstract: Provided are a conotoxin peptide ?-CPTx-btl05 and a derivative polypeptide. The amino acid sequence of the conotoxin peptide is indicated by SEQ ID NO: 1. Also provided are a conotoxin peptide preparation method and uses of the conotoxin peptide in the treatment of diseases related to a calcium ion channel.

Abstract: Provided is a new conotoxin peptide ?-CPTx-btl01. The conotoxin peptide ?-CPTx-btl01 has derivative polypeptide that has an amino acid sequence indicated by SEQ ID NO:1, or has derivative polypeptide that has an amino acid sequence indicated by SEQ ID NO:1 and that is formed after substitution, addition or deletion of one or more amino acids are performed and has original functions. Also provided is polynucleotide for coding the peptide, comprising a constructed body of the polynucleotide, an expression carrier and transformed cells. A peptide preparation method and uses in the treatment of diseases related to a calcium ion channel.

Abstract: A gate structure includes at least one spacer defining a gate region over a semiconductor substrate, a gate dielectric layer disposed on the gate region over the semiconductor substrate, a first work function metal layer disposed over the gate dielectric layer and lining a bottom surface of an inner sidewall of the spacer, and a filling metal partially wrapped by the first work function metal layer. The filling metal includes a first portion and a second portion, wherein the first portion is between the second portion and the semiconductor substrate, and the second portion is wider than the first portion.

Abstract: A method for producing the anode material of a lithium ion battery from flexible graphite powder, comprising (A) providing a dry flexible graphite, and pulverizing the dry flexible graphite by a pulverizing step, and filtering the dry flexible graphite with a sieve screen to obtain a uniform flexible graphite powder, (B) performing a ball-grinding step for the uniform flexible graphite powder by mixing with a solvent to obtain a liquid containing flexible graphite; (C) coating the liquid containing flexible graphite on a metal foil, and performing a rolling step to obtain an anode material. Then, the anode material is processed in its shape and is formed into an anode electrode plate. Thereafter, the anode electrode plate is stacked with a lower cover of the battery, a separating paper, a cathode electrode plate, a spring sheet and an upper cover of the battery to assemble the lithium ion battery.

Abstract: Provided are a conotoxin peptide ?-CPTx-btl04 and a derivative polypeptide. The amino acid sequence of the conotoxin peptide is indicated by SEQ ID NO: 1. Also provided are a conotoxin peptide preparation method and uses of the conotoxin peptide in the treatment of diseases related to a calcium ion channel.

Abstract: Provided is a new conotoxin peptide ?-CPTx-btl02. The conotoxin peptide ?-CPTx-btl02 has derivative polypeptide that has an amino acid sequence indicated by SEQ ID NO:1, or has derivative polypeptide that has an amino acid sequence indicated by SEQ ID NO:1 and that is formed after substitution, addition or deletion of one or more amino acids are performed and has original functions. Also provided is polynucleotide for coding the peptide, comprising a constructed body of the polynucleotide, an expression carrier and transformed cells. A peptide preparation method and uses in the treatment of diseases related to a calcium ion channel.

Abstract: Provided are a conotoxin peptide ?-CPTx-bt103 and a derivative polypeptide. The amino acid sequence of the conotoxin peptide is indicated by SEQ ID NO: 1. Also provided are a conotoxin peptide preparation method and uses of the conotoxin peptide in the treatment of diseases related to a calcium ion channel.